By Cecilia Butini Sanofi SA on Thursday backed its yearly guidance and reported higher sales for the first quarter, driven by its specialty care and vaccine businesses. The French pharma. | April 27, 2023
French drugmaker Sanofi on Thursday posted better-than-expected earnings for the first quarter as continued gains from anti-inflammatory drug Dupixent more than offset declining sales from an. | April 27, 2023
In his latest research note, analyst Michael Leuchten confirms his recommendation. The broker UBS is keeping its Neutral rating. The target price is unchanged and still at EUR 100. | April 27, 2023
Sanofi : Consensus-beating Q1, guidance unchanged marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.